Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.

Source:http://linkedlifedata.com/resource/pubmed/id/10613317

Int. J. Radiat. Oncol. Biol. Phys. 1999 Dec 1 45 5 1227-33

Download in:

View as

General Info

PMID
10613317